Fate Therapeutics Inc. buy EF Hutton Acquisition Co. I
Start price
01.03.23
/
50%
€5.72
Target price
01.03.24
€9.37
Performance (%)
26.81%
End price
02.03.24
€7.25
Summary
This prediction ended on 02.03.24 with a price of €7.25. The BUY prediction by EF_Hutton_Acquisitio finished with a performance of 26.81%. EF_Hutton_Acquisitio has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fate Therapeutics Inc. | -2.633% | -2.633% | 20.092% | -79.327% |
| iShares Core DAX® | -3,51 % | -8,75 % | -1,00 % | 48,50 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % | 14,22 % | 78,81 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % | 24,87 % | 51,56 % |
| iShares S&P 500 | -2,60 % | -2,23 % | 9,20 % | 60,51 % |
Comments by EF_Hutton_Acquisitio for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $10.00 price target on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten